Tech
Stories by Nadine McGrath
News
Top 10 at 11: Who’s got their ears on after a $2.1 million purchase order?
Director Trades
Skin in the game: Which ASX directors are backing a nickel price recovery?
News
Top 10 at 11: Enova inks rare earth Brazil deal, Credit Clear upgrades FY24 guidance
Health & Biotech
Q+A: Dimerix CEO on upcoming milestone Phase III interim trial results
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘up and down’ reporting season
Health & Biotech
These ASX biotechs want to tackle cancer head-on for better outcomes
News
Top 10 at 11: Sayona Mining falls after Piedmont Lithium plans to sell out
Health & Biotech
‘Significant potential’: This ASX stock is winning the race to make cancer care heart-safe
Health & Biotech
ASX stocks striving to inject youthfulness into an aging world population
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Health & Biotech